ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Isala at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Isala takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions centre on adjusting cancer drug infusions and dosing schedules. They examine nivolumab dosing intervals, pembrolizumab infusion reactions, and faster rituximab infusions.

OrganizationESMO 2026 Attendance
Isala
Zwolle, Netherlands
Cancer centre & hospital
Teaching hospital with an oncology center in Zwolle, Netherlands.
Poster
Fri Oct 23
13:00–15:00
Optimizing oncology care: A pharmacokinetics-driven approach to extending nivolumab dosing intervals
ePoster session 11
Gastrointestinal cancersMelanoma & skin cancersGenitourinary cancersNursing & supportive care
Poster
Sat Oct 24
12:00–12:45
Incidence of IRRs in 10-minute pembrolizumab infusion in everyday oncology practice
Saturday Poster Display session 3
Gastrointestinal cancersGynaecological cancersLung & thoracic cancersBreast cancerMelanoma & skin cancersGenitourinary cancersNursing & supportive care
Poster
Mon Oct 26
12:00–12:45
Accelerated rituximab infusion up to 15 minutes in haematological malignancies: A prospective pilot study
Monday Poster Display session 2
Haematological malignanciesNursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Isala

Tell us what you sell and we’ll find the people at Isala most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction